Best of Obesity Forum: Personalizing Management and Case Challenges is organized by Healio.
Release Date: October 31, 2023
Expiration Date: October 30, 2024
Activity Description:
Obesity continues to be a significant health concern worldwide. According to the World Health Organization (WHO), obesity rates have tripled since 1975, and in 2016, more than 1.9 billion adults were overweight, with 650 million of them classified as obese. The prevalence of obesity varies by region, with the highest rates observed in North America, Europe, and the Middle East. In the United States, the obesity rate is particularly high, with more than one-third of adults classified as obese. Obesity is associated with numerous health complications, including an increased risk of cardiovascular disease, stroke, type 2 diabetes mellitus, sleep apnea, gallbladder disease, osteoarthritis, and certain types of cancer. It also contributes to a lower quality of life and increased healthcare costs. Among the groups at risk for obesity are youths aged 2 to 19 years, of whom 19.3% are estimated to have obesity. Efforts to combat obesity include lifestyle interventions such as diet and exercise, anti-obesity medications, and surgery. However, the ongoing rise in obesity rates suggests that more work is needed to address this global health challenge. This session, Personalizing Management and Case Challenges, will incorporate didactic presentations covering the patient experience; pharmacological management of obesity including addressing negative perceptions and rationale for its use; obesity in children and adolescents; and interactive, case-based discussions.
Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Select patients with overweight and obese who may be at high risk of complications and may benefit from timely interventions for weight management.
• Incorporate interprofessional coordination of care, patient preferences/perspectives, and shared decision-making regarding evidence-based obesity treatments.
• Discuss the negative perceptions associated with early-generation anti-obesity medications (AOMs), improvements in the safety and efficacy profiles of current AOMs, and the rationale for their early use in clinical practice.
• Implement the most recent clinical data for medication management of overweight and obesity in children and adolescents.
• Apply the pharmacological management of overweight and obesity based on evidence-based interventions, patient needs, and recent and long-term clinical data including evidence regarding weight regain after cessation of medication.